✦ LIBER ✦

Strategic Treatment Interruptions During Imatinib Treatment of Chronic Myelogenous Leukemia

✍ Scribed by Dana Paquin; Peter S. Kim; Peter P. Lee; Doron Levy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imatinib Mesylate in the Treatment of Ch

✍ Gautam Borthakur; Jorge E. Cortes 📂 Article 📅 2004 🏛 Carden Jennings Publishing 🌐 English ⚖ 108 KB

The Role of Imatinib in the Treatment of

✍ Dax Kurbegov, Hagop M. Kantarjian, Dr Moshe Talpaz 📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 142 KB

Management of conjunctival chemosis seco

✍ Jiangang Jin; Hu Chen; Lvxian Cao 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Imatinib treatment in chronic myelogenou

✍ Massimo Breccia; Fabio Efficace; Giuliana Alimena 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Transient trisomy 8 abnormality in Phila

✍ M. KIM; S. LEE; C. K. JUNG; J. LIM; S. G. CHO; D. W. KIM; Y. KIM; K. HAN; W. S. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Resolution of leukemic retinopathy follo

✍ John B Christoforidis; Daniel J DeAngelo; Donald J D’Amico 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 100 KB